Glaxo appears on TV for the first time since the Avandia safety story broke, with Jean-Pierre Garnier, GlaxoSmithKline CEO & CNBC's Mike Huc...

...GlaxoSmithKline Plc, talks with Bloomberg's Ellen Braitman from Washington about the safety of the company's Avandia diabetes drug. Glaxo representatives and officials of the U.S. Food and Drug ...

David Graham, associate director of science and medicine for the Food and Drug Administration's Office of Surveillance and Epidemiology, talks with Bloomberg's Allan Dodds Frank in Gaithersburg, ...

A Glaxo-funded study found there is no significant increase in the risk of heart disease among patients who took Avandia when compared to th...

...Glaxo-Smith Kline's diabetes drug, Avandia, was in front of Congress Wednesday. A medical expert said Glaxo executives threatened to sue when he first question the treatment's safety in 1999. ...